These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 30041488)

  • 21. Erythropoietin (EPO) ameliorates obesity and glucose homeostasis by promoting thermogenesis and endocrine function of classical brown adipose tissue (BAT) in diet-induced obese mice.
    Kodo K; Sugimoto S; Nakajima H; Mori J; Itoh I; Fukuhara S; Shigehara K; Nishikawa T; Kosaka K; Hosoi H
    PLoS One; 2017; 12(3):e0173661. PubMed ID: 28288167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases.
    Yamashita S; Masuda D; Matsuzawa Y
    Curr Atheroscler Rep; 2020 Jan; 22(1):5. PubMed ID: 31974794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Peroxisome Proliferator-activated Receptor (PPAR)α Agonist and PPARγ Antagonist, Z-551, Ameliorates High-fat Diet-induced Obesity and Metabolic Disorders in Mice.
    Shiomi Y; Yamauchi T; Iwabu M; Okada-Iwabu M; Nakayama R; Orikawa Y; Yoshioka Y; Tanaka K; Ueki K; Kadowaki T
    J Biol Chem; 2015 Jun; 290(23):14567-81. PubMed ID: 25907553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment.
    Yokote K; Yamashita S; Arai H; Araki E; Suganami H; Ishibashi S; Of The K-Study Group OB
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator (SPPARMα), on urinary protein excretion in IgA nephropathy with hypertriglyceridemia.
    Tanaka A; Nakamura T; Sato E; Chihara A; Node K
    CEN Case Rep; 2020 May; 9(2):141-146. PubMed ID: 31950425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipolysis and thermogenesis in adipose tissues as new potential mechanisms for metabolic benefits of dietary fiber.
    Han SF; Jiao J; Zhang W; Xu JY; Zhang W; Fu CL; Qin LQ
    Nutrition; 2017 Jan; 33():118-124. PubMed ID: 27461561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double-blind placebo-controlled clinical trials.
    Yokote K; Yamashita S; Arai H; Araki E; Matsushita M; Nojima T; Suganami H; Ishibashi S
    Cardiovasc Diabetol; 2021 May; 20(1):96. PubMed ID: 33947390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.
    Sairyo M; Kobayashi T; Masuda D; Kanno K; Zhu Y; Okada T; Koseki M; Ohama T; Nishida M; Sakata Y; Yamashita S
    J Atheroscler Thromb; 2018 Feb; 25(2):142-152. PubMed ID: 28781340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy.
    Tomita Y; Lee D; Miwa Y; Jiang X; Ohta M; Tsubota K; Kurihara T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-obesity effects of boiled tuna extract in mice with obesity induced by a high-fat diet.
    Kim Y; Kwon MJ; Choi JW; Lee MK; Kim C; Jung J; Aprianita H; Nam H; Nam TJ
    Int J Mol Med; 2016 Oct; 38(4):1281-8. PubMed ID: 27498820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel selective PPARα modulator, pemafibrate promotes ischemia-induced revascularization through the eNOS-dependent mechanisms.
    Kawanishi H; Ohashi K; Ogawa H; Otaka N; Takikawa T; Fang L; Ozaki Y; Takefuji M; Murohara T; Ouchi N
    PLoS One; 2020; 15(6):e0235362. PubMed ID: 32584895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mice fed fish oil diet and upregulation of brown adipose tissue thermogenic markers.
    Bargut TC; Silva-e-Silva AC; Souza-Mello V; Mandarim-de-Lacerda CA; Aguila MB
    Eur J Nutr; 2016 Feb; 55(1):159-69. PubMed ID: 25612928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and efficacy of pemafibrate for prevention of maternal high-fat intake-induced glucose metabolic dysfunction in offspring.
    Imai M; Liu S; Yano A; Suzuki Y; Mogi M; Sugiyama T
    Biochem Pharmacol; 2024 Sep; 227():116454. PubMed ID: 39069137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent activation of liver X receptor and peroxisome proliferator-activated receptor alpha exacerbates hepatic steatosis in high fat diet-induced obese mice.
    Gao M; Bu L; Ma Y; Liu D
    PLoS One; 2013; 8(6):e65641. PubMed ID: 23762402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor α modular (SPPARMα), in atherosclerosis model using low density lipoprotein receptor knock-out swine with balloon injury.
    Konishi H; Miyauchi K; Onishi A; Suzuki S; Fuchimoto D; Shitara J; Endo H; Wada H; Doi S; Naito R; Ogita M; Dohi T; Kasai T; Daida H
    PLoS One; 2020; 15(11):e0241195. PubMed ID: 33201888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenofibrate (PPARalpha agonist) induces beige cell formation in subcutaneous white adipose tissue from diet-induced male obese mice.
    Rachid TL; Penna-de-Carvalho A; Bringhenti I; Aguila MB; Mandarim-de-Lacerda CA; Souza-Mello V
    Mol Cell Endocrinol; 2015 Feb; 402():86-94. PubMed ID: 25576856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model.
    Tomita Y; Ozawa N; Miwa Y; Ishida A; Ohta M; Tsubota K; Kurihara T
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinnamaldehyde Ameliorates Diet-Induced Obesity in Mice by Inducing Browning of White Adipose Tissue.
    Zuo J; Zhao D; Yu N; Fang X; Mu Q; Ma Y; Mo F; Wu R; Ma R; Wang L; Zhu R; Liu H; Zhang D; Gao S
    Cell Physiol Biochem; 2017; 42(4):1514-1525. PubMed ID: 28719892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor
    Yang Y; Xu X; Wu H; Yang J; Chen J; Morisseau C; Hammock BD; Bettaieb A; Zhao L
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel fatty acid mimetic with pan-PPAR partial agonist activity inhibits diet-induced obesity and metabolic dysfunction-associated steatotic liver disease.
    Sahin C; Melanson JR; Le Billan F; Magomedova L; Ferreira TAM; Oliveira AS; Pollock-Tahari E; Saikali MF; Cash SB; Woo M; Romeiro LAS; Cummins CL
    Mol Metab; 2024 Jul; 85():101958. PubMed ID: 38763495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.